A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers
Clinical trial NCT04564456 · COMPLETED
Trial details
- NCT number
- NCT04564456
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2020-10-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.